Exhibit 10.1
MARINUS PHARMACEUTICALS, INC.
Amended And Restated
CHANGE IN CONTROL SEVERANCE PLAN
The Company adopted the Marinus Pharmaceuticals, Inc. Change in Control Severance Plan, originally effective as of November 7, 2016, and amended and restated effective as of December , 2024 for the benefit of certain employees of the Company, on the terms and conditions hereinafter stated. All capitalized terms used herein are defined in Section 1 hereof. The Plan, as set forth herein, is intended to help retain qualified employees, maintain a stable work environment and provide economic security to eligible employees in the event of certain terminations of employment.
-2-
-3-
-4-
-5-
-6-
Unless a more favorable treatment is otherwise provided in an individual agreement with an Eligible Employee or Former Employee, in the event it shall be determined that any payment or benefit whether paid or payable pursuant to the terms of this Plan or otherwise pursuant to or by reason of any other agreement, policy, plan, program or arrangement (collectively, a “Payment”), to or for the benefit of an Eligible Employee or Former Employee, would be subject to the excise tax imposed by Section 4999 of the Code, or any successor provision thereto, or any similar tax imposed by state or local law, or any interest or penalties with respect to such excise tax (such tax or taxes, together with any such interest and penalties, are hereafter collectively referred to as the “Excise Tax”), then the aggregate amount of Payments payable to the Eligible Employee or Former Employee shall be reduced to the Safe Harbor Amount, with such reduction being applied first to the cash payments under Section 2.3 hereof and then to other benefits provided hereunder; provided however that such reduction shall not be effected in the event that the net amount of Payments received or receivable by the Eligible Employee or Former Employee, after giving effect to the imposition of the Excise Tax (and all other applicable taxes) exceeds the net amount of such Payments received or receivable by the Eligible Employee or Former Employee after giving effect to the reduction.
-7-
The Plan may be terminated or amended by the Board at any time; provided, however, that during the Change in Control Protection Period, (a) the Plan may not be terminated and (b) the Plan may not be amended if such amendment would in any manner be adverse to the interests of any Eligible Employee or Former Employee. For the avoidance of doubt, (a) any action taken by the Company or the Plan Administrator to cause an Eligible Employee or Former Employee to no longer be designated as a Tier I Employee, Tier II Employee, or Tier III Employee, as the case may be, or to decrease the benefits for which an Eligible Employee or Former Employee is eligible, and (b) any amendment to this Section 5 following the occurrence of a Change in Control shall be treated as an amendment to the Plan which is adverse to the interests of any Eligible Employee or Former Employee.
-8-
Plan Administrator
c/o Marinus Pharmaceuticals, Inc.
5 Radnor Corporate Center, Suite 500
100 Matsonford Rd.
Radnor, PA 19087
This written notice will be given to the employee within ninety (90) days after the Plan Administrator receives the application, unless special circumstances require an extension of time, in which case, the Plan Administrator has up to an additional ninety (90) days for
-9-
processing the application. If an extension of time for processing is required, written notice of the extension will be furnished to the applicant before the end of the initial ninety (90)-day period. This notice of extension will describe the special circumstances necessitating the additional time and the date by which the Plan Administrator is to render his or her decision on the application. If written notice of denial of the application for benefits is not furnished within the specified time, the application shall be deemed to be denied. The applicant will then be permitted to appeal the denial in accordance with the Review Procedure described below.
Plan Administrator
c/o Marinus Pharmaceuticals, Inc.
5 Radnor Corporate Center, Suite 500
100 Matsonford Rd.
Radnor, PA 19087
A request for review must set forth all of the grounds on which it is based, all facts in support of the request and any other matters that the applicant feels are pertinent. The Plan Administrator may require the applicant to submit additional facts, documents or other material as he or she may find necessary or appropriate in making his or her review.
-10-
-11-
EXHIBIT A
Tier I Employees
Chief Executive Officer of the Company; Chief Financial and Chief Operating Officer of the Company; General Counsel of the Company; Chief Medical Officer of the Company and Chief Commercial Officer of the Company
Severance Period - 18 months
Bonus Multiplier 1.0
Tier II Employees
Chief Scientific Officer of the Company; Chief Regulatory and Quality Assurance Officer of the Company; Chief People and Investor Relations Officer of the Company; and Chief Chemistry, Manufacturing and Controls Officer of the Company
Severance Period - 12 months
Bonus Multiplier 1.0
Tier III Employees
All Other Eligible Employees
Notwithstanding anything in the Plan to contrary, for the purposes of all Eligible Employees other than Tier 1 Employees and Tier II Employees, the Change in Control Benefit as defined in Section 2.3 of the Plan shall consist of a single lump sum payment equal to two (2) weeks of the Eligible Employee’s or Former Employee’s base salary (as in effect immediately prior to the Change in Control or immediately prior to the Severance Date, whichever is higher) multiplied by the Years of Service applicable to such Eligible Employee or Former Employee; provided, however, that regardless of years of service, no Change in Control Benefit shall be equal to an amount less than four (4) weeks of the Eligible Employee’s or Former Employee’s base salary (as in effect immediately prior to the Change in Control or immediately prior to the Severance Date whichever is higher).
A-1